| 1 |
CheMBL Affinity Phenotypic Cellular Interaction Assay ID: CHEMBL1125966
|
| 2 |
Clinical pipeline report, company report or official report of Humanetics.
|
| 3 |
Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
|
| 4 |
Bcr-Abl tyrosine kinase inhibitors: a patent review.Expert Opin Ther Pat. 2015 Apr;25(4):397-412.
|
| 5 |
CheMBL Affinity Phenotypic Cellular Interaction Assay ID: CHEMBL1126165
|
| 6 |
CheMBL Affinity Phenotypic Cellular Interaction Assay ID: CHEMBL1125976
|
|
|
|
|
|
|